Currently, the share price for Alivus Life Sciences Ltd. is delayed. Login to view live prices.
Alivus Life Sciences Ltd.
₹1,017.45
NSE
-- ( -- %) 1D
- Prev. Close1,017.45
- Upper Circuit1,228.80
- Lower Circuit819.20
Analyst Sentiment For Alivus Life Sciences Ltd.
There seem to be no recommendations on this stock from the analyst universe covered
Returns
Alivus Life Sciences Ltd.'s Info & Management
Glenmark Life Sciences is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.
- Executive Director,Managing Director,Whole Time Director,Chief Executive OfficerYasir Yusufali Rawjee
- Chief Financial OfficerMr. Tushar Mistry
- Senior Vice President,Head(Human Resources)Mr. Sumantra Mitra
- Group Vice President(Research & Development)Dr. Palle V R Acharyulu
- Vice President,Head(Corporate Quality)Mr. Navin Kumar Agrawal
- Senior Vice President,Head(Regulatory Affairs)Mr. Mathew George
FAQs on Alivus Life Sciences Ltd.
What is the share price of Alivus Life Sciences Ltd.?
Alivus Life Sciences Ltd. share price is ₹1,015.80 as of March 13, 2025, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Alivus Life Sciences Ltd.?
The 52-week high and low of Alivus Life Sciences Ltd. is ₹1,331.45 and ₹680.05 respectively as of March 13, 2025, 03:29 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Alivus Life Sciences Ltd.?
The trailing twelve month (TTM) PB ratio of Alivus Life Sciences Ltd. is 5.38 as of March 14, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Alivus Life Sciences Ltd.?
The Upper Circuit of Alivus Life Sciences Ltd. is ₹1,229.
The Lower Circuit of Alivus Life Sciences Ltd. is ₹819.
What is the ROE of Alivus Life Sciences Ltd.?
Alivus Life Sciences Ltd. reported an ROE of 21.07% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Alivus Life Sciences Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Alivus Life Sciences Ltd., Promoter held 75%, the FII held 6.7%, DII held 4.9% and the public held 13.4% of the total shares.
How to buy Alivus Life Sciences Ltd. Share?
You can easily buy shares of Alivus Life Sciences Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Alivus Life Sciences Ltd.?
The fair value of Alivus Life Sciences Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer